On May 16, the Department of Justice proposed regulations to reschedule cannabis from a Schedule I to a Schedule III substance. The rule would significantly loosen federal restrictions on cannabis, opening new opportunities to industry members, researchers and cannabis users. Still, major questions loom. Join Shareholders Melissa Kuipers Blake and Josh Weiss as they discuss how the rescheduling process will play out, tax implications, what this means for the SAFER Banking bill and many other questions created by this announcement.
THIS DOCUMENT IS INTENDED TO PROVIDE YOU WITH GENERAL INFORMATION REGARDING THE RESCHEDULING OF CANNABIS. THE CONTENTS OF THIS DOCUMENT ARE NOT INTENDED TO PROVIDE SPECIFIC LEGAL ADVICE. IF YOU HAVE ANY QUESTIONS ABOUT THE CONTENTS OF THIS DOCUMENT OR IF YOU NEED LEGAL ADVICE AS TO AN ISSUE, PLEASE CONTACT THE ATTORNEYS LISTED OR YOUR REGULAR BROWNSTEIN HYATT FARBER SCHRECK, LLP ATTORNEY. THIS COMMUNICATION MAY BE CONSIDERED ADVERTISING IN SOME JURISDICTIONS.